Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow

被引:63
作者
Dworzak, MN
Fritsch, G
Fleischer, C
Printz, D
Froschl, G
Buchinger, P
Mann, G
Gadner, H
机构
[1] Children's Cancer Research Institute, St Anna Kinderspital, A-1090 Vienna
关键词
B cell precursor; lymphopoiesis; bone marrow; phenotype; flow cytometry;
D O I
10.1038/sj.leu.2400732
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied the differentiation profiles of B cell precursors (BCP) in normal and post-chemotherapy pediatric bone marrow (BM) using multiparameter flow cytometry. The goal of our study was to draw a comprehensive phenotypic map of the three major maturational BCP stages in BM. By correlating lineage-associated markers, CD45RA, and several adhesion molecules, the stage-specific patterns were found to differ in certain details from previously published concepts. Among the earliest BCP, a subset of CD34(+)CD10(lo) precursors was repeatedly observed in addition to the well characterized CD34(+)CD10(hl)CD19(+) majority of cells. Only two-thirds of these CD34(+)CD10(lo) cells expressed CD19. However, uniformity of phenotypic features, absence of T lineage markers, and the regeneration kinetics after chemotherapy suggest the B lineage affiliation of the CD34(+)CD10(lo) precursors in general. In the more mature BCP, expression of CD10, CD20, cytoplasmic and surface mu chains (c mu and s mu) was observed to overlap more than previously recognized. We found that CD20 and c mu appear early during B cell ontogeny (already on CD34(+) BCP), and that CD10 is lost late, following the onset of s mu expression. Differences between normal and post-chemotherapy BM specimens regarding the phenotypic appearance of BCP were exclusively due to differences in the subset composition, as post-chemotherapy samples showed a preponderance of immature stages. Our observations may build a framework for comparing leukemic cells with their normal counterparts to define possible leukemia-associated aberrations useful for residual disease studies.
引用
收藏
页码:1266 / 1273
页数:8
相关论文
共 43 条
  • [1] BERNARD A, 1988, J IMMUNOL, V140, P1802
  • [2] BERNARD G, 1995, J IMMUNOL, V154, P26
  • [3] BODGER MP, 1981, J IMMUNOL, V127, P2269
  • [4] CAMPANA D, 1991, BONE MARROW TRANSPL, V8, P429
  • [5] CAMPANA D, 1985, J IMMUNOL, V134, P1524
  • [6] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - METHODOLOGIC ADVANCES AND CLINICAL-SIGNIFICANCE
    CAMPANA, D
    PUI, CH
    [J]. BLOOD, 1995, 85 (06) : 1416 - 1434
  • [7] THE IMMUNOLOGICAL DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA
    CAMPANA, D
    COUSTANSMITH, E
    JANOSSY, G
    [J]. BLOOD, 1990, 76 (01) : 163 - 171
  • [8] FLOW CYTOMETRIC ASSESSMENT OF HUMAN MIC2 EXPRESSION IN BONE-MARROW, THYMUS, AND PERIPHERAL-BLOOD
    DWORZAK, MN
    FRITSCH, G
    BUCHINGER, P
    FLEISCHER, C
    PRINTZ, D
    ZELLNER, A
    SCHOLLHAMMER, A
    STEINER, G
    AMBROS, PF
    GADNER, H
    [J]. BLOOD, 1994, 83 (02) : 415 - 425
  • [9] GORE SD, 1991, BLOOD, V77, P1681
  • [10] DIFFERENTIATION-LINKED LEUKEMOGENESIS IN LYMPHOCYTES
    GREAVES, MF
    [J]. SCIENCE, 1986, 234 (4777) : 697 - 704